p.110 抽出テキスト

218. Pickham D, Helfenbein E, Shinn JA, et al. High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study. Crit Care Med 2012; 40: 394-399. PMID: 22001585 219. Tisdale JE, Jaynes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 2013; 6: 479-487. PMID: 23716032 220. Aiba T, Shimizu W, Hidaka I, et al. Verapamil suppresses torsade de pointes by reducing transmural dispersion of repolarization and preventing early afterdepolarization in acquired model of long-QT syndrome. Circulation 2002; 106 Suppl: II-22. 221. Donger C, Denjoy I, Berthet M, et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997; 96: 2778-2781. PMID: 9386136 222. Roden DM. Taking the “idio” out of “idiosyncratic”: predicting torsades de pointes. Pacing Clin Electrophysiol 1998; 21: 1029- 1034. PMID: 9604234 223. Napolitano C, Schwartz PJ, Brown AM, et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol 2000; 11: 691-696. PMID: 10868744 224. Weeke P, Mosley JD, Hanna D, et al. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome. J Am Coll Cardiol 2014; 63: 1430-1437. PMID: 24561134 225. Banai S, Tzivoni D. Drug therapy for torsade de pointes. J Cardiovasc Electrophysiol 1993; 4: 206-210. PMID: 8269292 226. Pinski SL, Eguía LE, Trohman RG. What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers. Pacing Clin Electrophysiol 2002; 25: 1612- 1615. PMID: 12494620 227. Johannesen L, Vicente J, Mason JW, et al. Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial. Clin Pharmacol Ther 2016; 99: 214-223. PMID: 26259627 228. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-1396. PMID: 1309182 229. Bergonti M, Ciconte G, Cruzalegui Gomez J, et al. Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome. J Am Coll Cardiol 2024; 84: 921-933. PMID: 39197982 230. Bergonti M, Sacher F, Arbelo E, et al. Implantable loop recorders in patients with Brugada syndrome: the BruLoop study. Eur Heart J 2024; 45: 1255-1265. PMID: 38445836 231. García-Izquierdo E, Scrocco C, Palacios-Rubio J, et al. Arrhythmia detection using an implantable loop recorder after a negative electrophysiology study in Brugada syndrome: Observations from a multicenter international registry. Heart Rhythm 2024; 21: 1317- 1324. PMID: 38458509 232. Scrocco C, Ben-Haim Y, Devine B, et al. Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: A United Kingdom single-center experience. Heart Rhythm 2022; 19: 70-78. PMID: 34487893 233. Miles C, Boukens BJ, Scrocco C, et al. Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation. Circulation 2023; 147: 1622-1633. PMID: 37216437 234. Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 2011; 123: 1270-1279. PMID: 21403098 235. Nakano Y, Shimizu W. Brugada Syndrome as a Major Cause of Sudden Cardiac Death in Asians. JACC Asia 2022; 2: 412-421. PMID: 36339362 236. Shimizu W, Kusumoto FM, Agbayani MF, et al. Statement from the Asia Summit: Current state of arrhythmia care in Asia. Heart Rhythm O2 2023; 4: 741-755. PMID: 38034890 237. Nademanee K, Chung FP, Sacher F, et al. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry). Circulation 2023; 147: 1568-1578. PMID: 36960730 238. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293-296. PMID: 9521325 239. Hosseini SM, Kim R, Udupa S, et al. National Institutes of Health Clinical Genome Resource Consortium. Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome. Circulation 2018; 138: 1195-1205. PMID: 29959160 240. Yamagata K, Horie M, Aiba T, et al. Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry. Circulation 2017; 135: 2255-2270. PMID: 28341781 241. Ishikawa T, Kimoto H, Mishima H, et al. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome. Eur Heart J 2021; 42: 2854- 2863. PMID: 34219138 242. Doundoulakis I, Pannone L, Chiotis S, et al. SCN5A gene variants and arrhythmic risk in Brugada syndrome: An updated systematic review and meta-analysis. Heart Rhythm 2024; 21: 1987-1997. PMID: 38614189 243. Sroubek J, Probst V, Mazzanti A, et al. Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis. Circulation 2016; 133: 622-630. PMID: 26797467 244. Kusumoto FM, Bailey KR, Chaouki AS, et al. Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 2018; 15: e253-e274. PMID: 29097318 245. Gaita F, Cerrato N, Giustetto C, et al. Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study. Circulation 2023; 148: 1543-1555. PMID: 37830188 246. Russo V, Caturano A, Migliore F, et al. IBRYD Study Group. Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study. Heart Rhythm 2024; 21: 555-561. PMID: 38242222 247. Sieira J, Conte G, Ciconte G, et al. A score model to predict risk of events in patients with Brugada Syndrome. Eur Heart J 2017; 38: 1756-1763. PMID: 28379344 248. Kawada S, Morita H, Antzelevitch C, et al. Shanghai Score System for Diagnosis of Brugada Syndrome: Validation of the Score System and System and Reclassification of the Patients. JACC Clin Electrophysiol 2018; 4: 724-730. PMID: 29929664 249. Rattanawong P, Mattanapojanat N, Mead-Harvey C, et al. Predicting arrhythmic event score in Brugada syndrome: Worldwide pooled analysis with internal and external validation. Heart Rhythm 2023; 20: 1358-1367. PMID: 37355026 250. Kamakura T, Takagi M, Komatsu Y, et al. Japan Idiopathic Ventricular Fibrillation (J-IVFS) Investigators. Validation of novel risk prediction models in patients with Brugada syndrome: A multicenter study in Japan. Heart Rhythm 2025; 22: 1710-1717. PMID: 39288881 251. Nakamura T, Aiba T, Shimizu W, et al. Prediction of the Presence of Ventricular Fibrillation From a Brugada Electrocardiogram Using Artificial Intelligence. Circ J 2023; 87: 1007-1014. PMID: 36372400 252. Ishikawa T, Masuda T, Hachiya T, et al. Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci. Eur Heart J 2024; 45: 2320- 2332. PMID: 38747976 253. Wijeyeratne YD, Tanck MW, Mizusawa Y, et al. SCN5A Mutation Type and a Genetic Risk Score Associate Variably With Brugada Syndrome Phenotype in SCN5A Families. Circ Genom Precis Med 2020; 13: e002911. PMID: 33164571 254. Hermida JS, Lemoine JL, Aoun FB, et al. Prevalence of the brugada syndrome in an apparently healthy population. Am J Cardiol 2000; 86: 91-94. PMID: 10867101 255. Junttila MJ, Raatikainen MJ, Karjalainen J, et al. Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J 2004; 25: 874-878. PMID: 15140536 256. Gallagher MM, Forleo GB, Behr ER, et al. Prevalence and significance of Brugada-type ECG in 12,012 apparently healthy European subjects. Int J Cardiol 2008; 130: 44-48. PMID: 18054807 257. Atarashi H, Ogawa S, Harumi K, et al. Idiopathic Ventricular Fibrillation Investigators. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. J Am Coll Cardiol 2001; 37: 1916-1920. PMID: 11401132 258. Sakabe M, Fujiki A, Tani M, et al. Proportion and prognosis of healthy people with coved or saddle-back type ST segment elevation in the right precordial leads during 10 years follow-up. Eur Heart J 2003; 24: 1488-1493. PMID: 12919772